Endometrial morphology in women of reproductive age with PCOS

Background. Polycystic ovary syndrome is the most common endocrine disease in women, affecting various aspects of health. The results of several studies indicate an increased prevalence of hyperplasia or endometrial cancer in women with PCOS, but there are no clinical recommendations on the need for assessing the endometrial condition in PCOS and approaches to predictions. Aim: to determine the frequency and structure of endometrial pathology among reproductive-aged patients with PCOS. Materials and methods. In a cross-sectional survey, we examined 1200 women who are subject to annual preventive examination. The research period was May - December 2017. The diagnosis of PCOS was made according to the consensus criteria adopted in May 2003 in Rotterdam. Participants signed informed consent for the survey. Results. We found 102 women with a verified diagnosis of PCOS. 56 of them completed their participation in the study; the median age was 32.19 ± 5.67 years. All patients underwent a biopsy of the endometrium with immunohistochemical examination. Features of the structure of the endometrium: a normal endometrial characteristic in 24 women (42.9 %), chronic endometritis -18 specimens (58.1 %), abnormal hypoplastic endometrium - 6 (19.4 %), simple endometrial hyperplasia -1 (3.2 %) adenocarcinoma -1 (3.2 %), proliferative endometrium with disorders - 7(22.6 %). Conclusions. In the examined women with PCOS there was a high incidence of histologically confirmed endometrial pathology, in the structure of which chronic endometritis predominates. The foregoing necessitates new research and development of clinical protocols for the timely detection of endometrial pathology in PCOS.

polycystic ovary syndrome, endometrium, chronic endometritis, endometrial hyperplasia, endometrial cancer

1. Balen A. (2001). Polycystic ovary syndrome and cancer. Hum Reprod Update, 7 (6), 522-525.

2. Christian R.C., Dumesic D.A., Behrenbeck T., Oberg A.L., Sheedy P.F. 2nd, Fitzpatrick L.A. (2003). Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 88 (6), 2562-2568.

3. Fearnley E.J., Marquart L., Spurdle A.B., Weinstein P., Webb P.M. (2010). Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. Cancer Causes Control, 21 (12), 2303-2308.

4. Giudice L.C. (2006). Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab, 20 (2), 235-244.

5. Gottschau M., Kjaer S.K., Jensen A., Munk C., Mellemkjaer L. (2015). Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study. Gynecol Oncol, 136 (1), 99-103.

6. Homburg R., Levy T., Berkovitz D., Farchi J., Feldberg D., Ashkenazi J., Ben-Rafael Z. (1993). Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril, 59 (3), 527-531.

7. Lizneva D., Kirubakaran R., Mykhalchenko K., Suturina L., Chernukha G., Diamond M.P., Azziz R. (2016). Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and metaanalysis. Fertil Steril, 106 (06), 1510-1520

8. Lizneva D., Suturina L., Walker W., Brakta S., Gavrilova-Jordan L., Azziz R. (2016). Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril, 106 (01), 6-15.

9. Navaratnarajah R., Pillay O.C., Hardiman P. (2008). Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med, 26 (1), 62-71.

10. Palomba S., Falbo A., Russo T., Tolino A., Orio F., Zullo F. (2010). Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril, 94 (5), 1805-1811.

11. Schouten L.J., Goldbohm R.A., van den Brandt P.A. (2004). Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst, 96 (21), 1635-1638.